Study protocol suggests consumption of
probiotics in kefir positively alters the composition of the gut
microbiome and may be linked to behavioral effects and improvements
in sleep
MORTON
GROVE, Ill., May 8, 2024
/PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), a leading
U.S. supplier of kefir and fermented probiotic products that
support the microbiome, applauds the recent study protocol
titled, "Randomised controlled trial of the effects of kefir on
behaviour, sleep and the microbiome in children with ADHD: a study
protocol," published by the British Medical Journal (BMJ) Open
Journal. The trial will test diet-based intervention targeting gut
health to support the wellbeing of children with ADHD, as previous
research has suggested that daily consumption of the probiotics in
dairy kefir can positively alter the composition of the microbiome,
thus leading to a reduction in ADHD symptoms and improvements in
sleep.1
While additional research is needed, Lifeway is encouraged by
the initial findings of a potential link between the probiotics and
improvements in ADHD symptoms in children.
"At Lifeway Foods, it is our mission to help people live
healthier, happier lives while providing the best in probiotic and
nutritious foods," said Julie
Smolyansky, CEO of Lifeway Foods. "We continue to be
inspired and reassured by the advancements in microbiome research
and the positive effects of probiotic foods on mental and physical
health. As the range of potential health benefits associated with
probiotics continue to expand, we're thrilled to be part of the
path forward."
As America's leading supplier of kefir, Lifeway Kefir is made
with 12 live and active cultures, and packed with protein, calcium
and vitamin D. Each product is loaded with probiotics, which
research suggests may help support the microbiome and may lead to
positive improvements in gut and mental health.
To learn more about Lifeway and its products, visit
lifewaykefir.com. To view the full study protocol published by BMJ
open, visit: bmjopen.bmj.com/content/13/12/e071063.
About Lifeway Foods, Inc.
Lifeway Foods, Inc., which
has been recognized as one of Forbes' Best Small Companies, is
America's leading supplier of the probiotic, fermented beverage
known as kefir. In addition to its line of drinkable kefir, the
company also produces a variety of cheeses and a ProBugs line for
kids. Lifeway's tart and tangy fermented dairy products are now
sold across the United States,
Mexico, Ireland and France. Learn how Lifeway is good for more
than just you at lifewayfoods.com.
Forward-Looking Statements
This release (and
oral statements made regarding the subjects of this release)
contains "forward-looking statements" as defined in the Private
Securities Litigation Reform Act of 1995 regarding, among other
things, future operating and financial performance, product
development, market position, business strategy and objectives.
These statements use words, and variations of words, such as
"continue," "build," "future," "increase," "drive," "believe,"
"look," "ahead," "confident," "deliver," "outlook," "expect," and
"predict." Other examples of forward-looking statements may
include, but are not limited to, (i) statements of Company plans
and objectives, including the introduction of new products, or
estimates or predictions of actions by customers or suppliers, (ii)
statements of future economic performance, and (III) statements of
assumptions underlying other statements and statements about
Lifeway or its business. You are cautioned not to rely on these
forward-looking statements. These statements are based on current
expectations of future events and thus are inherently subject to
uncertainty. If underlying assumptions prove inaccurate or known or
unknown risks or uncertainties materialize, actual results could
vary materially from Lifeway's expectations and projections. These
risks, uncertainties, and other factors include: price competition;
the decisions of customers or consumers; the actions of
competitors; changes in the pricing of commodities; the effects of
government regulation; possible delays in the introduction of new
products; and customer acceptance of products and services. A
further list and description of these risks, uncertainties, and
other factors can be found in Lifeway's Annual Report on Form 10-K
for the fiscal year ended December 31,
2023, and the Company's subsequent filings with the SEC.
Copies of these filings are available online at
https://www.sec.gov, http://lifewaykefir.com/investor-relations/,
or on request from Lifeway. Information in this release is as of
the dates and time periods indicated herein, and Lifeway does not
undertake to update any of the information contained in these
materials, except as required by law. Accordingly, YOU SHOULD NOT
RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION
CONTAINED IN ANY ARCHIVED PRESS RELEASE.
General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net
- Lawrence K, Fibert P, Hobbs J, et al Randomised controlled
trial of the effects of kefir on behaviour, sleep and the
microbiome in children with ADHD: a study protocol BMJ Open
2023;13:e071063. doi: 10.1136/bmjopen-2022-071063
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-applauds-new-research-examining-the-impact-of-probiotics-in-dairy-kefir-on-the-microbiome-in-children-with-adhd-302139679.html
SOURCE Lifeway Foods, Inc.